Syntis Bio
Milton, MA
Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy. The company's drug uses novel formulations for oral therapies that target specific tissues, enabling users to increase bioavailability.
syntis.bioEmploybl Premium
Get the inside track on Syntis Bio
Premium profiles, AI research on tech stack and hiring, 61,000+ ATS job listings, saved searches, and an AI chat that knows the SF startup scene.
- AI chat about Syntis Bio's culture, stack, and interview process
- Save jobs and get alerts on new openings
- Full premium profiles across our company index
- 7-day free trial, then $25/mo. Cancel anytime.
Company Details
Founded
- 2022
Employees
- Between 5 - 20 employees
Raised
- $53,372,180
Headquarters Location
- Milton, MA
Public
- No
Acquired
- No
CEO
Rahul Dhanda
Founders
- Rahul DhandaGiovanni Traverso
Company Collections
These are collections Syntis Bio is a part of. Click on the collection name to view similar companies.
Syntis Bio's Industries
Syntis Bio Headquarters Location
50 Adams Street Suite 870073, Milton, MA, 02187
Total Amount Raised: $53,372,180
Syntis Bio Funding Rounds
Series A
$33,000,000
Grant
$5,000,000
Series A
$33,000,000
Series A Investors
Cerberus Capital ManagementApollo LabsW.R. BerkleyTouchdown VenturesPortal InnovationsWoori Venture PartnersSafar PartnersBold Capital PartnersColorcon VenturesMansueto InvestmentsGrant
$5,000,000
Grant Investors
National Institutes of Health (NIH)Seed
$15,372,179
Seed
$15,372,179
Seed Investors
Portal InnovationsColorcon VenturesTouchdown VenturesBold Capital PartnersSafar Partners
Syntis Bio Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Syntis Bio.